secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K/A
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001213900-25-002769
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma granted additional 180-day Nasdaq bid price compliance extension to July 7, 2025
--------------------------------------------------------------------------------

- Nasdaq extended deadline from January 6, 2025 to July 7, 2025 for minimum $1.00 bid price requirement.
- Company must close at $1.00 or higher for at least 10 consecutive trading days to regain compliance.
- ABVC may consider a reverse stock split to meet the bid price requirement.
- No immediate impact on Nasdaq listing; stock continues trading under symbol ABVC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025002769/0001213900-25-002769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025002769/ea0227316-8ka1_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-002769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer